Erectile dysfunction drugs save the lives of cancer patients, the drug contains a PDE5 inhibitor that has been proven in terms of safety, well tolerated, for use by patients worldwide.
The researchers suggested that the use of the drug for people with esophageal cancer would not cause an uncontrolled erection.
A team of experts from the University of Southampton, UK found that drugs for erectile dysfunction can increase the effects of chemotherapy for esophageal cancer.
The study was published in the Journal of Cell Reports Medicine, on June 22.
The drug is also called a PDE5 inhibitor, which has a vasodilating effect on the penis, used to treat erectile dysfunction.
Scientists found the drug could reverse chemotherapy resistance by targeting cancer cells (CAF) residing around the tumor.
PDE5 inhibitors in combination with chemotherapy help to significantly shrink esophageal tumors compared to the use of this therapy alone.
